Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Fieve Clinical Research
477
mi
from 43215
New York, NY
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Fieve Clinical Research
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Richmond Behavioral Associates
468
mi
from 43215
Staten Island, NY
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Richmond Behavioral Associates
468
mi
from 43215
Staten Island, NY
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Carolina Clinical Trials
509
mi
from 43215
Charleston, NC
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Carolina Clinical Trials
509
mi
from 43215
Charleston, NC
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
New Hope Clinical Research
349
mi
from 43215
Charlotte, NC
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
New Hope Clinical Research
349
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Richard H. Weisler, MD, PA
372
mi
from 43215
Raleigh, NC
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Richard H. Weisler, MD, PA
372
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Neuro-Behavioral Clinical Research, Inc.
103
mi
from 43215
Canton, OH
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Neuro-Behavioral Clinical Research, Inc.
103
mi
from 43215
Canton, OH
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Patient Priority Clinical sites, LLC
86
mi
from 43215
Cincinnati, OH
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Patient Priority Clinical sites, LLC
86
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Ohio State University Department of Psychiatry
2
mi
from 43215
Columbus, OH
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Ohio State University Department of Psychiatry
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Charak Clinical Research Center
124
mi
from 43215
Garfield Heights, OH
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Charak Clinical Research Center
124
mi
from 43215
Garfield Heights, OH
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Lindner Center of HOPE
79
mi
from 43215
Mason, OH
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Lindner Center of HOPE
79
mi
from 43215
Mason, OH
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Professional Psychiatric Services
79
mi
from 43215
Mason, OH
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Professional Psychiatric Services
79
mi
from 43215
Mason, OH
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
IPS Research
849
mi
from 43215
Oklahoma City, OK
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
IPS Research
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Red River Medical Research Center
850
mi
from 43215
Oklahoma City, OK
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Red River Medical Research Center
850
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Sooner Clinical Research
850
mi
from 43215
Oklahoma City, OK
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Sooner Clinical Research
850
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Paradigm Research Professionals, Llc
849
mi
from 43215
Oklahoma City, OK
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Paradigm Research Professionals, Llc
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Summit Research Network
2028
mi
from 43215
Portland, OR
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Summit Research Network
2028
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Lehigh Center for Clinical Research
397
mi
from 43215
Allentown, PA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Lehigh Center for Clinical Research
397
mi
from 43215
Allentown, PA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Suburban Research Associates
403
mi
from 43215
Media, PA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Suburban Research Associates
403
mi
from 43215
Media, PA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Dr. Cherian Verghese
403
mi
from 43215
Norristown, PA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Dr. Cherian Verghese
403
mi
from 43215
Norristown, PA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Coastal Carolina Research Center
523
mi
from 43215
Mount Pleasant, SC
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research Center
523
mi
from 43215
Mount Pleasant, SC
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical NeuroScience Solutions, Inc.
503
mi
from 43215
Memphis, TN
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical NeuroScience Solutions, Inc.
503
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Research Strategies of Memphis, LLC
508
mi
from 43215
Memphis, TN
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Research Strategies of Memphis, LLC
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Donald J. Garcia Jr., MD
1074
mi
from 43215
Austin, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Donald J. Garcia Jr., MD
1074
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research
1057
mi
from 43215
Austin, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research
1057
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
BioBehavioral Research of Austin
1059
mi
from 43215
Austin, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
BioBehavioral Research of Austin
1059
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Relaro Medical Trials
904
mi
from 43215
Dallas, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Relaro Medical Trials
904
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
El Campo Clinical Trials
1056
mi
from 43215
El Campo, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
El Campo Clinical Trials
1056
mi
from 43215
El Campo, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
North Texas Clinical Trials
938
mi
from 43215
Fort Worth, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
North Texas Clinical Trials
938
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Earle Research
992
mi
from 43215
Houston, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Earle Research
992
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Red Oak Psychiatry Associates, PA
991
mi
from 43215
Houston, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Red Oak Psychiatry Associates, PA
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
1137
mi
from 43215
San Antonio, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
1137
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Family Psychiatry of The Wood
974
mi
from 43215
The Woodlands, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Family Psychiatry of The Wood
974
mi
from 43215
The Woodlands, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Grayline Clinical Drug Trials
951
mi
from 43215
Wichita Falls, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Grayline Clinical Drug Trials
951
mi
from 43215
Wichita Falls, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric And Behavioral Solutions
1513
mi
from 43215
Salt Lake City, UT
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric And Behavioral Solutions
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
PRA Health Sciences
1512
mi
from 43215
Salt Lake City, UT
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
PRA Health Sciences
1512
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia
277
mi
from 43215
Charlottesville, VA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia
277
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric Alliance of The Blue Ridge
275
mi
from 43215
Charlottesville, VA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric Alliance of The Blue Ridge
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
1998
mi
from 43215
Bellevue, WA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
1998
mi
from 43215
Bellevue, WA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Institute of Medical Sciences
2001
mi
from 43215
Bothell, WA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Institute of Medical Sciences
2001
mi
from 43215
Bothell, WA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
IRIS Research
440
mi
from 43215
Smyrna, GA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
IRIS Research
440
mi
from 43215
Smyrna, GA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Phoenix Medical Research
622
mi
from 43215
Prairie Village, KA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Phoenix Medical Research
622
mi
from 43215
Prairie Village, KA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
BTC of New Bedford
642
mi
from 43215
New Bedford, MA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
BTC of New Bedford
642
mi
from 43215
New Bedford, MA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Eastside Therapeutic Resource
2000
mi
from 43215
Everett, WA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Eastside Therapeutic Resource
2000
mi
from 43215
Everett, WA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Houston Clinical Trials, LLC
993
mi
from 43215
Bellaire, TX
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Houston Clinical Trials, LLC
993
mi
from 43215
Bellaire, TX
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Irvine Center for Clinical Research
1956
mi
from 43215
Irvine, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Irvine Center for Clinical Research
1956
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Meridien Research
861
mi
from 43215
Bradenton, FL
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Meridien Research
861
mi
from 43215
Bradenton, FL
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Finger Lakes Clinical Research
356
mi
from 43215
Rochester, NY
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Finger Lakes Clinical Research
356
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Synergy San Diego
1944
mi
from 43215
Lemon Grove, CA
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
An Open-label, Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Synergy San Diego
1944
mi
from 43215
Lemon Grove, CA
Click here to add this to my saved trials